News

The Company
5
Press Release
September 10, 2025

GNQ Insilico Launches Revolutionary AI-Driven Assessment Platform to Transform Precision Medicine and Drug Development

lti-Agentic AI Platform Powered by Proprietary Systems Biology Engine Delivers Personalized Therapy Optimization and Investment…
Read More
The Company
4
Press Release
July 9, 2025

GNQ Insilico Unveils Multi-Pathway Therapeutic Formulation for ALS Leveraging proprietary Drug Assessment Platform

GNQ Insilico, Inc. (“GNQ” or “the Company”), a cutting-edge TechBio platform company, announced results from…
Read More
The Company
4
Press Release
July 7, 2025

GNQ’s Drug Assessment Platform Enhances Non-Small Cell Lung Cancer Treatment by Extending Efficacy Beyond Universal Resistance Barrier

GNQ Insilico, Inc. (“GNQ” or “the Company”), a TechBio platform company, demonstrated the advanced capabilities…
Read More
The Company
4
Press Release
December 15, 2024

GNQ presents at Quantum Rising Conference alongside Deloitte & IBM Quantum

Sudhir Saxena, Chief Technology Officer of GNQ Insilico, Inc. (GNQ), was invited by Deloitte Consulting…
Read More
The Company
4
Press Release
June 18, 2024

GNQ Insilico’s AI-Driven Digital Twins Platform Shows Promising Results in Simulating Effects of a Drug on Synthesized Digital Twins

GNQ Insilico’s AI-Driven Digital Twins Platform Shows Promising Results in Simulating Effects of a Drug…
Read More
The Company
4
Press Release
March 30, 2024

GNQ Unveils AI-Powered Platform Prototype Delivering 128% AUC Improvement in Personalized Clomiphene Dosing Optimization

GNQ Insilico, Inc. (“GNQ” or “the Company”), a TechBio platform company, announced the successful development…
Read More
The Company
4
Press Release
March 4, 2024

GNQ Insilico Announces Collaboration with Fortune 100 Company to Develop Next-Generation Clinical Trial Platform

SAN FRANCISCO, CALIFORNIA, USA, March 4, 2024 /EINPresswire.com/ — GNQ Insilico Inc. (“GNQ”), a company…
Read More
The Company
3
Press Release
November 30, 2020

Agentix Biopharma CEO, Rudy Mazzocchi, Discusses the Company’s Growth Strategy with The Stock Day Podcast

Phoenix, Arizona--(Newsfile Corp. - November 11, 2020) - The Stock Day Podcast welcomed Agentix Biopharma…
Read More
The Company
4
Press Release
June 23, 2020

Agentix Corp. entered into a Share Exchange Agreement with GSL Healthcare

On May 28, 2020, Agentix Corp., a Nevada corporation (the "Company"), entered into a Share…
Read More
The Company
5
Press Release
September 10, 2025

GNQ Insilico Launches Revolutionary AI-Driven Assessment Platform to Transform Precision Medicine and Drug Development

lti-Agentic AI Platform Powered by Proprietary Systems Biology Engine Delivers Personalized Therapy Optimization and Investment…
Read More
The Company
4
Press Release
July 9, 2025

GNQ Insilico Unveils Multi-Pathway Therapeutic Formulation for ALS Leveraging proprietary Drug Assessment Platform

GNQ Insilico, Inc. (“GNQ” or “the Company”), a cutting-edge TechBio platform company, announced results from…
Read More
The Company
4
Press Release
July 7, 2025

GNQ’s Drug Assessment Platform Enhances Non-Small Cell Lung Cancer Treatment by Extending Efficacy Beyond Universal Resistance Barrier

GNQ Insilico, Inc. (“GNQ” or “the Company”), a TechBio platform company, demonstrated the advanced capabilities…
Read More
The Company
4
Press Release
December 15, 2024

GNQ presents at Quantum Rising Conference alongside Deloitte & IBM Quantum

Sudhir Saxena, Chief Technology Officer of GNQ Insilico, Inc. (GNQ), was invited by Deloitte Consulting…
Read More
The Company
4
Press Release
June 18, 2024

GNQ Insilico’s AI-Driven Digital Twins Platform Shows Promising Results in Simulating Effects of a Drug on Synthesized Digital Twins

GNQ Insilico’s AI-Driven Digital Twins Platform Shows Promising Results in Simulating Effects of a Drug…
Read More